Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Oculofacial AB
AB
Active
Org 5569364218
Observatoriegatan 19, 113 29
Stockholm
Medical specialists activities
· NACE 8622
Est. 2013
1 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Oculofacial AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
1M
2M
2M
2M
2021
2M
2022
2M
2023
2M
2024
2M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 961
2 367
2 149
2 207
1 637
Staff expenses
—
−909
−917
−883
−779
EBITDA
743
1 026
784
941
430
Depreciation & amort.
−17
−23
−37
−37
−33
EBIT
726
1 004
747
903
397
Net financials
−144
−159
4
7
4
Profit before tax
871
845
751
911
401
Tax
−182
−211
−156
−189
−88
Net profit
689
634
595
721
313
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
3 804
3 461
3 827
4 218
4 076
Equity
2 853
3 225
3 520
3 936
3 932
Long-term debt
0
—
—
—
—
Short-term debt
952
236
306
282
144
Total debt
952
236
306
282
144
Financial ratios
5-year trend
EBITDA margin
26.3%
This company
15.8%
Market median
+66% vs market
2021
2025
Equity ratio
96.5%
This company
38.2%
Market median
+153% vs market
2021
2025
Return on equity
8.0%
This company
18.4%
Market median
-57% vs market
2021
2025
Net profit margin
19.1%
This company
8.1%
Market median
+136% vs market
2021
2025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
2021
2025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Oculofacial AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network